NSC |
Compound |
Enrichment |
Correlation |
NSC 716768 |
Null |
0.0107933723273943 |
0.072554645 |
NSC 726262 |
1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one |
0.0107933723273943 |
0.1972614 |
NSC 728220 |
1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone |
0.0107933723273943 |
0.19664769 |
NSC 731201 |
ethyl 6,7-dichloro-3-phenyl-2-quinoxalincarboxylate 1,4-dioxide |
0.0107933723273943 |
0.26762676 |
NSC 734562 |
6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride |
0.0107933723273943 |
0.15659615 |
NSC 740276 |
5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide |
0.0107933723273943 |
0.29262879 |
NSC 740504 |
5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.0107933723273943 |
0.097800481 |
NSC 88054 |
Null |
0.0107933723273943 |
0.29094157 |
NSC 10520 |
Null |
0.0110679092462696 |
0.18496731 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.0110679092462696 |
0.27741897 |